Abstract
Dibenzobarrelene (I) was used as a starting compound for the synthesis of some new 3a,4,9,9a-tetrahydro-4,9-[1,2]benzeno-1H-benzo[f]isoindole-1,3(2H)-diones, N-substituted with: 4-toluenesulfonyloxy, III; butoxy, IV; 3-bromopropoxy, V; 3-(4-phenylpiperazin-1-yl)propoxy, VI; 3-chloro-3-oxopropyl, VIII; 3-(4-phenylpiperazin-1-yl)-3-oxopropyl, IXa; 3-(4-methylpiperazin-1-yl)-3-oxopropyl, IXb; 3-oxo-3-(piperidin-1-yl)propyl, X; 3-morpholino-3-oxopropyl, XI; 3-phenylamino-3-oxopropyl, XII; 2-acetylaminoethyl, XIV; 2-aminoethyl, XV, and 2-acetoxyethyl, XVI. Newly synthesized compounds were characterized by IR, 1H and 13C NMR, and mass spectral data. Selected products were tested for antimicrobial activity.
Similar content being viewed by others
References
Braña, M. F., Domínguez, G., Sáez, B., Romerdahl, C., Robinson, S., & Barlozzari, T. (2002). Synthesis and antitumour activity of new dendritic polyamines-(imide-DNA-intercalator) conjugates: potent Lck inhibitors. European Journal of Medicinal Chemistry, 37, 541–551. DOI: 10.1016/S0223-5234(02)01362-4.
Cegła, M. T., Boksa, J., Chojnacka-Wójcik, E., & Misztal, S. (1996). 4-Aryl-1-piperazinylalkyl derivatives of 1,2,3,4-tetrahydro-β-carboline ring system. Synthesis and preliminary in vivo studies. Die Pharmazie, 51, 932–936.
Clar, E. (1931). Zur Kenntnis mehrkerniger aromatischer Kohlenwasserstoffe und ihrer Abkömmlinge, XI. Mitteil.: Über die Konstitution des Anthracens, II.: Bemerkungen zu einer Arbeit von Otto Diels und Kurt Alder. Berichte der Deutschen Chemischen Gesellschaft, 64, 2194–2200. DOI: 10.1002/cber.19310640854.
Cruickshank, R., Duguid, J. P., Marmion, B. P., & Swain, R. H. A. (Eds.) (1973). Medical Microbiology (12th ed., vol. 2, pp. 196–202). Edinburgh, UK: Churchill Livingstone.
Desai, R. A., & Samant, S. D. (2000). Preparation of N-[ω-(4-aryl-1-piperazinyl)ethyl/propyl]-3-hydroxyphthalimides. Indian Journal of Chemistry, 39B, 455–457.
Fernández Braña, M., Fernández, A., Garrido, M., López-Rodríguez, M. L., Morcillo, M. J., & Sanz, A. M. (1989). Synthesis, structure and cytostatic activity of a series of N-substituted 3,4-diphenyl-1H-pyrrole-2,5-diones. Chemical & Pharmaceutical Bulletin, 37, 2710–2712.
Goldfarb, D. S. (2009). Method for altering the lifespan of eukaryotic organisms. U.S. Patent Application Publication No. US 2009/0163545 A1. Alexandria, VA, USA: United States Patent and Trademark Office.
Jindal, D. P., Bedi, V., Jit, B., Karkra, N., Guleria, S., Bansal, R., Palusczak, A., & Hartmann, R. W. (2005). Synthesis and study of some new N-substituted imide derivatives as potential anticancer agents. Il Farmaco, 60, 283–290. DOI: 10.1016/j.farmac.2005.01.011.
Khadilkar, B. M., & Samant, S. D. (1993). Synthesis and pharmacology of 2-[3-(4-aryl-1-piperazinyl)-2-hydroxypropyl/3-oxopropyl/propoxy]-1H-isoindole-1,3(2H)-diones. Indian Journal of Chemistry, 32B, 1137–1142.
Khadilkar, B. M., & Samant, S. D. (1986). Synthesis and pharmacology of some 2-[3-(4-aryl-1-piperazinyl)propyl]-1H-benz[d]isoquinoline-1,3-(2H)-diones/2,5-pyrrolidones. Journal of Indian Chemical Society, 63, 529–530.
Kitahonoki, K., & Kido, R. (1975). N,N′-Alkylen-bis-dibenzobicyclo-octanopyrrolidin-Verbindungen und ihre Herstellung. German Patent No. DE 1695796. Munich, Germany: German Patent and Trademark Office.
Kitahonoki, K., & Kido, R. (1970). N,N′-alkylene-bis-dibenzobicyclooctanopyrrolidine compounds and production thereof. U.S. Patent No. 3,513,174. Arlington, VA, USA: U.S. Patent Office.
Kitamogi, K., & Kido, R. (1967). N,N′-Alkylidenebis(acid imides). Japan Patent No. JP 9574. Tokyo, Japan: Japan Patent Office.
Kossakowski, J., & Jarocka, M. (2001). Synthesis of new N-substituted cyclic imides with an expected anxiolytic activity. XVII. Derivatives of 1-ethoxybicyclo[2.2.2]-oct-5-one-2,3-dicarboximide. Il Farmaco, 56, 785–789. DOI: 10.1016/S0014-827X(01)01144-2.
Légora Machado, A., Moreira Lima, L., Araújo, J. X., Jr., Fraga, C. A. M., Gonçalves Koatz, V. L., & Barreiro, E. J. (2005). Design, synthesis and antiinflammatory activity of novel phthalimide derivatives, structurally related to thalidomide. Bioorganic & Medicinal Chemistry Letters, 15, 1169–1172. DOI: 10.1016/j.bmcl.2004.12.012.
Saikia, R., Singh, A. K., & Bhattacharjee, G. (1988). N-(Sulfony1oxy)phthalimides and analogues are potent inactivators. Indian Journal of Chemistry, 27A, 790–793.
Salvati, M. E., Balog, A., Shan, W., Wei, D. D., Pickering, D., Attar, R. M., Geng, J., Rizzo, C. A., Gottardis, M. M., Weinmann, R., Krystek, S. R., Sack, J., An, Y., & Kish, K. (2005). Structure based approach to the design of bicyclic-1H-isoindole-1,3(2H)-dione based androgen receptor antagonists. Bioorganic & Medicinal Chemistry Letters, 15, 271–276. DOI: 10.1016/j.bmcl.2004.10.085.
Samant, S. D., & Kulkarni, R. A. (1979). Synthesis and pharmacology of N-(N 4-aryl-N 1-piprazinylalkyl)phthalimides: CNS depressants. Journal of Indian Chemical Society, 56, 1002.
Sieklucka-Dziuba, M., Rajtar, G., & Kleinrok, Z. (1995). Some pharmacological properties and cumulative, subchronic and chronic toxicity of 9-methyl-2-[3-(4-phenyl-1-piperazinylpropyl)]-1,2,3,4-tetrahydro-β-carbolin-1-one (B-193). Polish Journal of Pharmacology, 47, 305–311.
Staniek, P., & Stoll, K. (1995). Imide nucleating agents for polymers. German Patent Application No. DE 19520262. Munich, Germany: German Patent Office.
Suzuki, K., Nagasawa, H., Uto, Y., Sugimoto, Y., Noguchi, K., Wakida, M., Wierzba, K., Terada, T., Asao, T., Yamada, Y., Kitazato, K., & Hori, H. (2005). Napthalimidobenzamide DB-51630: a novel DNA binding agent inducing p300 gene expression and exerting a potent anti-cancer activity. Bioorganic & Medicinal Chemistry, 13, 4014–4021. DOI: 10.1016/j.bmc.2005.03.053.
Weber, E., Finge, S., & Csoeregh, I. (1991). Modular design of hosts involving a rigid succinimide framework and N-bonded lateral groups. Crystalline inclusion properties and crystal structures of inclusion compounds with dioxane, MeOH, and DMF. Journal of Organic Chemistry, 56, 7281–7288. DOI: 10.1021/jo00026a018.
Wehner, W., Michaelis, K. P., & Schneider, R. (1981). Alkanolamid-beta-ketocarbonsäureester und ihre Verwendung zur Stabilisierung von chlorhaltigen Thermoplasten. European Patent Application No. EP 0022749. Munich, Germany: European Patent Office.
Wiczyńska, B., Chojnacka-Wójcik, E., Rokosz-Pelc, A., Mazela, H., & Przegaliński, E. (1989). Antiserotonin activity of 9-methyl-2-[3-(4-phenyl-1-piperazinylpropyl)]-1,2,3,4-tetrahydro-β-carbolin-1-one (B-193). Polish Journal of Pharmacology and Pharmacy, 41, 169–181.
Wu, Y.-H., Smith, K. R., Rayburn, J.W., & Kissel, J.W. (1969). Psychosedative agents. N-(4-phenyl-1-piperazinylalkyl)-substituted cyclic imides. Journal of Medicinal Chemistry, 12, 876–881. DOI: 10.1021/jm00305a037.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Khalil, A.EG.M., Berghot, M.A. & Gouda, M.A. Synthesis and study of some new N-substituted imide derivatives as potential antibacterial agents. Chem. Pap. 64, 637–644 (2010). https://doi.org/10.2478/s11696-010-0049-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.2478/s11696-010-0049-z